KRYSTAL BIOTECH, INC.

(KRYS)
  Rapport
Temps Différé Nasdaq  -  22:00 01/07/2022
67.47 USD   +2.76%
22/06Krystal Biotech soumet une demande de licence de produits biologiques à la FDA des États-Unis en vue d'obtenir l'approbation du B-VEC pour le traitement des patients atteints d'épidermolyse bulleuse dystrophique
CI
24/05KRYSTAL BIOTECH, INC. : Opinion positive de Goldman Sachs
ZM
09/05Krystal Biotech, Inc. annonce ses résultats pour le premier trimestre se terminant le 31 mars 2022
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur KRYSTAL BIOTECH, INC.
22/06KRYSTAL BIOTECH : Submits Biologics License Application to U.S. FDA Seeking Approval of B-..
22/06KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
22/06Krystal Biotech Files Biologics License Application With FDA for Skin Disease Drug Cand..
22/06Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B..
22/06Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B..
15/06TRANSCRIPT : Krystal Biotech, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare..
07/06Krystal Biotech to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
26/05KRYSTAL BIOTECH, INC. : Changes in Registrant's Certifying Accountant, Financial Statement..
23/05KRYSTAL BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
20/05KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
20/05Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the..
10/05TRANSCRIPT : Krystal Biotech, Inc. Presents at Bank of America 2022 Healthcare Conference,..
09/05Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q1 Loss $-1.99
09/05Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on O..
09/05KRYSTAL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
09/05Krystal Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 20..
03/05Krystal Biotech to Participate in Bank of America Merrill Lynch Global Healthcare Confe..
11/04Krystal Biotech Plans Home-Dosing Option in Study of Investigational Skin Disorder Ther..
11/04Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
11/04Krystal Biotech Announces Home Dosing in B-Vec Open Label Extension Study
28/03KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
28/03Krystal Biotech Says Trial of Skin Disease Treatment Met Primary and Secondary Endpoint..
28/03Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) o..
28/03Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) o..
28/03TRANSCRIPT : Krystal Biotech, Inc. - Special Call
28/03Krystal Biotech, Inc. - New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American ..
26/03New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American Academy of Dermatology A..
26/03Krystal Biotech, Inc., Announces New GEM-3 Phase 3 Results for B-VEC Presented at 2022 ..
24/03Krystal Biotech to Participate in H.C. Wainwright and Guggenheim Investor Conferences
23/03Jeune Aesthetics Announces Positive Clinical Phase 1 (PEARL-1 Study) Efficacy Results f..
22/03KRYSTAL BIOTECH : Jeune Aesthetics Announces Positive Clinical Phase 1 (PEARL-1 Study) Eff..
22/03KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
22/03TRANSCRIPT : Jeune Aesthetics, Inc, Krystal Biotech, Inc. - Special Call
21/03Krystal Biotech to Present at 2022 American Academy of Dermatology Annual Meeting
18/03Krystal Biotech to Present at 2022 American Academy of Dermatology Annual Meeting
15/03KRYSTAL BIOTECH : Announces Settlement with PeriphaGen, Inc - Form 8-K
15/03KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
15/03Krystal Biotech Settles Litigation With PeriphaGen
15/03Krystal Biotech Announces Settlement with PeriphaGen, Inc.
01/03KRYSTAL BIOTECH : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides..
28/02KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Change in Directors..
28/02Krystal Biotech, Inc. Announces Board Changes
28/02Krystal Biotech's Q4 Loss Widens
28/02KRYSTAL BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and ..
28/02Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 202..
28/02Krystal Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provide..
28/02NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
28/02Certain Commom Stock of Krystal Biotech, Inc. are subject to a Lock-Up Agreement Ending..
28/02Certain Restricted Stock Units of Krystal Biotech, Inc. are subject to a Lock-Up Agreem..
28/02Certain Stock Options of Krystal Biotech, Inc. are subject to a Lock-Up Agreement Endin..
24/02Krystal Biotech to Participate in Cowen's 42nd Annual Health Care Conference
18/01KRYSTAL BIOTECH : Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand S..
18/01KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers, Regulation FD Disclosur..
18/01Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand ..
18/01Krystal Biotech, Inc. Announces Management Changes
2021INSIDER SELL : Krystal Biotech
2021INSIDER SELL : Krystal Biotech
2021KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements a..
2021Krystal Biotech Prices $200 Million Offering at $75/Share
2021Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
2021Krystal Biotech Starts $200 Million Share Sale
2021Krystal Biotech Announces Proposed $200 Million Public Offering of Common Stock
2021KRYSTAL BIOTECH : Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK&#..
2021KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
2021Health Care Stocks Hanging On For Narrow Gains Near Monday Close
2021Krystal Biotech Genetic Skin Disorder Drug Trial Meets Primary Endpoint; Shares Rally
2021Health Care Stocks Rising Monday Afternoon
2021Top Midday Gainers
2021Wall Street Set for Rebound After Omicron-Induced Slump
2021Health Care Stocks Rally Premarket Monday
2021Health Care
2021Top Premarket Gainers
2021Krystal Biotech Soars Premarket as Genetic Skin Disorder Drug Trial Meets Primary Endpo..
2021TRANSCRIPT : Krystal Biotech, Inc. - Special Call
2021Krystal Biotech Shares More Than Double After Dystrophic EB Trial Meets Objectives
1  2  3  4  5Suiv.
Prochain événement sur KRYSTAL BIOTECH, INC.